Darunavir Tablet, Film Coated
Product Images NDC 31722-088

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Darunavir (NDC 31722-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Darunavir600mgcontainerlabel (Darunavir600mgcontainerlabel)

Darunavir Tablets 600 mg film-coated oral tablets label by Camber Pharmaceuticals, Inc. The label indicates a package size of 60 tablets, includes storage instructions, dosage reference, a U.S. contact number, manufacturer information, and a barcode. It also features a warning about medicines that should not be taken with darunavir.*

FDA Label Image

Darunavir800mgcontainerlabel (Darunavir800mgcontainerlabel)

Darunavir Tablets 800 mg film-coated tablets label from Camber Pharmaceuticals, Inc. The label indicates each film-coated tablet contains 800 mg of darunavir. It includes a red alert warning about medicines that should not be taken with darunavir. The bottle contains 30 tablets, with recommended storage and dosage instructions referenced. The label also provides a U.S. contact number and manufacturing information.*

FDA Label Image

Darunavircamberlogo (Darunavircamberlogo)

FDA Label Image

Darunavirchemicalstructure (Darunavirchemicalstructure)

Chemical structure of Darunavir showing the molecular arrangement including rings and functional groups typical of this HIV protease inhibitor.*

FDA Label Image

Darunavirfigure1 (Darunavirfigure1)

A comparative bar chart showing geometric mean ratios (GMR) with 90% confidence intervals for total and unbound area under the curve (AUC) and minimum concentration (Cmin) of Darunavir/ritonavir administered twice daily during the second and third trimesters. The chart compares pharmacokinetic parameters between these trimesters, with specific GMR values and confidence intervals listed.*

FDA Label Image

Darunavirfigure2 (Darunavirfigure2)

A pharmacokinetic graph showing the geometric mean ratio (GMR) with 90% confidence intervals for Darunavir/ritonavir once daily during the second and third trimesters of pregnancy. The chart compares total and unbound AUC and Cmin values, with data points indicated for both trimesters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.